116 related articles for article (PubMed ID: 6998875)
21. Pokeweed mitogen induced synthesis of human IgG and IgM in vitro. Technical aspects and the role of adherent cells.
Jahn S; Kiessig ST; Lukowsky A; Volk HD; Porstmann T; Grunow R; von Baehr R
Biomed Biochim Acta; 1986; 45(4):467-76. PubMed ID: 3707561
[TBL] [Abstract][Full Text] [Related]
22. Thymus dependence of the IgA response to sheep erythrocytes.
van Muiswinkel WB; van Soest PL
Immunology; 1975 Feb; 28(2):287-91. PubMed ID: 1091544
[TBL] [Abstract][Full Text] [Related]
23. Low molecular weight factors displaying augmenting activity for human antibody production in vitro.
Haraguchi S; Hongo T; Ishihara H; Matsuo T; Yoshida TO
Microbiol Immunol; 1987; 31(12):1181-96. PubMed ID: 2836711
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous and induced immunoglobulin secretion by synovial fluid B lymphocytes in rheumatoid arthritis.
Petersen J; Ingemann-Hansen T; Halkjaer-Kristensen JS
Ann Rheum Dis; 1984 Apr; 43(2):140-5. PubMed ID: 6324703
[TBL] [Abstract][Full Text] [Related]
25. Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes.
Pierce CW; Johnson BM; Gershon HE; Asofsky R
J Exp Med; 1971 Aug; 134(2):395-416. PubMed ID: 4934502
[TBL] [Abstract][Full Text] [Related]
26. Use of a human plaque-forming cell assay to study peripheral blood bursa-equivalent cell activation and excessive suppressor cell activity in humoral immunodeficiency.
Herrod HG; Buckley RH
J Clin Invest; 1979 May; 63(5):868-76. PubMed ID: 376549
[TBL] [Abstract][Full Text] [Related]
27. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
[TBL] [Abstract][Full Text] [Related]
28. Endothelial cells modulate both T-cell-dependent and T-cell-independent plaque-forming cell generation in vitro.
Teitel JM; Shore A; McBarron J; Leary PL; Schiavone A
Int Arch Allergy Appl Immunol; 1990; 91(1):66-73. PubMed ID: 2179140
[TBL] [Abstract][Full Text] [Related]
29. B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies.
Jones BM
Clin Exp Immunol; 1983 Mar; 51(3):461-9. PubMed ID: 6221842
[TBL] [Abstract][Full Text] [Related]
30. Conditions for induction of specific and polyclonal antibody production by Cowan 1 bacteria and by pokeweed mitogen.
Sjöberg O; Kurnick J
Scand J Immunol; 1980; 11(1):47-51. PubMed ID: 9537028
[TBL] [Abstract][Full Text] [Related]
31. Human B lymphocyte subsets. I. IgG-bearing B cell response to pokeweed mitogen.
Ault KA; Towle M
J Exp Med; 1981 Feb; 153(2):339-51. PubMed ID: 7017061
[TBL] [Abstract][Full Text] [Related]
32. The employment of the bactericidal and haemolytic plaque method for detection of 19S and 7S antibody-producing cells against somatic antigen of E. coli 086 in the primary response in rabbits.
Tlaskalová H; Sterzl J
Folia Biol (Praha); 1970; 16(2):102-13. PubMed ID: 4191335
[No Abstract] [Full Text] [Related]
33. Bispecific cells among IgM and IgG producers during the early phase of primary and secondary responses.
Couderc J; Birrien JL; Oriol R; Bleux C; Liacopoulos P
Eur J Immunol; 1975 Feb; 5(2):140-7. PubMed ID: 1241945
[TBL] [Abstract][Full Text] [Related]
34. Induction of human immunoglobulin secretion. I. Synergistic effect of B cell mitogen Cowan I plus T cell mitogens or factors.
Saiki O; Ralph P
J Immunol; 1981 Sep; 127(3):1044-7. PubMed ID: 6973576
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-2 is required for the induction of erythrocyte--specific antibody responses in human lymphocyte cultures.
Booth RJ; Pang GT; Watson JD
J Biol Response Mod; 1984; 3(2):206-18. PubMed ID: 6374045
[TBL] [Abstract][Full Text] [Related]
36. Autoreactive lymphocytes in thyroid disorders. Quantitation of anti-thyroglobulin antibody formation by a specific haemolytic plaque forming cell (PFC) assay.
Petersen J; Feldt-Rasmussen U; Larsen F; Siersbaek-Nielsen K
Acta Endocrinol (Copenh); 1986 Sep; 113(1):50-5. PubMed ID: 3532657
[TBL] [Abstract][Full Text] [Related]
37. Variability in generation of anti-sheep erythrocyte plaque-forming cells from cultures of human peripheral blood. Influence of monocytes.
Hollingsworth JW; Dunne JV; Small D; Rose JE; Vaughan JH
Int Arch Allergy Appl Immunol; 1980; 62(3):302-8. PubMed ID: 6993371
[TBL] [Abstract][Full Text] [Related]
38. The effects of RES 'blockade' on antibody formation. IV. Inhibition of plaque-forming cells in spleen cultures treated with carbon particles.
Sabet TY; Friedman H
Immunology; 1970 Nov; 19(5):843-53. PubMed ID: 4922035
[TBL] [Abstract][Full Text] [Related]
39. Activation of human B lymphocytes XVI. Cellular requirements, interactions, and immunoregulation of pokeweed mitogen-induced total-immunoglobulin producing plaque-forming cells in peripheral blood.
Fauci AS; Whalen G; Burch C
Cell Immunol; 1980 Aug; 54(1):230-40. PubMed ID: 6996843
[No Abstract] [Full Text] [Related]
40. Immunoglobulin production by tonsil lymphocytes before and after Epstein-Barr virus transformation.
Speirs JI; Konowalchuk J; Perelmutter L
Cell Immunol; 1982 Nov; 74(1):64-71. PubMed ID: 6297809
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
